Hannah C. Slater
Cited by
Cited by
Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies
L Wu, LL van den Hoogen, H Slater, PGT Walker, AC Ghani, CJ Drakeley, ...
Nature 528 (7580), S86-S93, 2015
Oral, ultra–long-lasting drug delivery: application toward malaria elimination goals
AM Bellinger, M Jafari, TM Grant, S Zhang, HC Slater, EA Wenger, S Mo, ...
Science translational medicine 8 (365), 365ra157-365ra157, 2016
The Relative Contribution of Symptomatic and Asymptomatic Plasmodium vivax and Plasmodium falciparum Infections to the Infectious Reservoir in a Low …
FG Tadesse, HC Slater, W Chali, K Teelen, K Lanke, M Belachew, ...
Clinical infectious diseases 66 (12), 1883-1891, 2018
The potential public health consequences of COVID-19 on malaria in Africa
E Sherrard-Smith, AB Hogan, A Hamlet, OJ Watson, C Whittaker, ...
Nature medicine 26 (9), 1411-1416, 2020
Pfhrp2-Deleted Plasmodium falciparum Parasites in the Democratic Republic of the Congo: A National Cross-sectional Survey
JB Parr, R Verity, SM Doctor, M Janko, K Carey-Ewend, BJ Turman, ...
The Journal of infectious diseases 216 (1), 36-44, 2017
Assessing the impact of next-generation rapid diagnostic tests on Plasmodium falciparum malaria elimination strategies
HC Slater, A Ross, AL Ouédraogo, LJ White, C Nguon, PGT Walker, ...
Nature 528 (7580), S94-S101, 2015
Predicting the current and future potential distributions of lymphatic filariasis in Africa using maximum entropy ecological niche modelling
H Slater, E Michael
PloS one 7 (2), e32202, 2012
The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density
HC Slater, A Ross, I Felger, NE Hofmann, L Robinson, J Cook, ...
Nature communications 10 (1), 1433, 2019
Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a …
MR Smit, EO Ochomo, G Aljayyoussi, TK Kwambai, BO Abong'o, T Chen, ...
The Lancet Infectious Diseases 18 (6), 615-626, 2018
Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study
OJ Brady, HC Slater, P Pemberton-Ross, E Wenger, RJ Maude, AC Ghani, ...
The Lancet Global Health 5 (7), e680-e687, 2017
Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial
AL Ouédraogo, GJH Bastiaens, AB Tiono, WM Guelbéogo, KC Kobylinski, ...
Clinical Infectious Diseases 60 (3), 357-365, 2015
Efficacy and risk of harms of repeat ivermectin mass drug administrations for control of malaria (RIMDAMAL): a cluster-randomised trial
BD Foy, H Alout, JA Seaman, S Rao, T Magalhaes, M Wade, S Parikh, ...
The Lancet 393 (10180), 1517-1526, 2019
The potential impact of adding ivermectin to a mass treatment intervention to reduce malaria transmission: a modelling study
HC Slater, PGT Walker, T Bousema, LC Okell, AC Ghani
The Journal of infectious diseases 210 (12), 1972-1980, 2014
Modelling the drivers of the spread of Plasmodium falciparum hrp2 gene deletions in sub-Saharan Africa
OJ Watson, HC Slater, R Verity, JB Parr, MK Mwandagalirwa, A Tshefu, ...
Elife 6, e25008, 2017
Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases
M Miglianico, M Eldering, H Slater, N Ferguson, P Ambrose, RS Lees, ...
Proceedings of the National Academy of Sciences 115 (29), E6920-E6926, 2018
Model-Based Geostatistical Mapping of the Prevalence of Onchocerca volvulus in West Africa
SJ O’Hanlon, HC Slater, RA Cheke, BA Boatin, LE Coffeng, SDS Pion, ...
PLoS neglected tropical diseases 10 (1), e0004328, 2016
Establishment of the Ivermectin Research for Malaria Elimination Network: updating the research agenda
CJ Chaccour, NR Rabinovich, H Slater, SE Canavati, T Bousema, ...
Malaria Journal 14, 1-8, 2015
False-negative malaria rapid diagnostic test results and their impact on community-based malaria surveys in sub-Saharan Africa
OJ Watson, KM Sumner, M Janko, V Goel, P Winskill, HC Slater, A Ghani, ...
BMJ global health 4 (4), e001582, 2019
Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa
HC Slater, JT Griffin, AC Ghani, LC Okell
Malaria journal 15, 1-11, 2016
Ivermectin as a novel complementary malaria control tool to reduce incidence and prevalence: a modelling study
HC Slater, BD Foy, K Kobylinski, C Chaccour, OJ Watson, J Hellewell, ...
The Lancet Infectious Diseases 20 (4), 498-508, 2020
The system can't perform the operation now. Try again later.
Articles 1–20